Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Using Microbial Genomics to Elucidate the Source of Central-line Associated Bloodstream Infections

NCT02271243 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.

NCT NCT02271243
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02271243 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Using Microbial Genomics to Elucidate the Source of Central-line Associated Bloodstream Infections
Lead sponsor
Boston Children's Hospital
Phase
Observational
Overall status
Recruiting
Start date
November 30, 2014
Completion date
December 31, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

central line-associated bloodstream infections, laboratory-confirmed bloodstream infection, mucosal barrier injury